Antibacterial agents: susceptibility In Vitro and In Vivo

Abstract

Antibacterial susceptibility testing methods measure the response of a bacterial strain to an antibacterial agent, thereby providing an essential guide to the treatment of infection.

Keywords: antibiotics; antibacterial agents; susceptibility testing; therapy; treatment of infection

References

Bergeron MG and Ouellette M (1998) Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory. Antimicrobial Agents and Chemotherapy 36: 2169–2172.

Daikos GL, Jackson GG, Lolans VT and Livermore DM (1990) Adaptive resistance to aminoglycoside antibiotics from first exposure down‐regulation. Journal of Infectious Diseases 162: 414–420.

Fish DN, Piscatelli SC and Danziger LH (1995) Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15: 279–291.

Gemmell CG (1997) Antibiotics and the immune system. In: O'Grady F, Lambert HP, Finch RG and Greenwood D (eds) Antibiotic and Chemotherapy, pp. 125–130. Edinburgh, UK: Churchill Livingstone.

Greenwood D (1985) The alteration of microbial growth curves by antibiotics. In: Habermehl K‐O (ed.) Rapid Methods and Automation in Microbiology and Immunology, pp. 497–503. Berlin: Springer

Greenwood D (1997) What's the use of susceptibility testing? Journal of Chemotherapy 9 (supplement 1): 7–12.

Howie JW (1962) Recent developments in chemotherapy. Lancet i: 1137–1140.

Ispahani P, Pearson NJ and Greenwood D (1987) An analysis of community and hospital‐acquired bacteraemia in a large teaching hospital in the United Kingdom. Quarterly Journal of Medicine 63: 427–440.

Kumana CR and Yuen KY (1994) Parenteral aminoglycoside therapy: selection, administration and monitoring. Drugs 47: 902–913.

National Committee for Clinical Laboratory Standards (1997) Performance standards for antimicrobial disk susceptibility tests – sixth edition; approved standard. NCCLS M2‐A6 17: 1–26.

Phillips I (1998) The subtleties of antibiotic resistance. Journal of Antimicrobial Chemotherapy 42: 5–12.

Report (1991) A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27 (supplement D): 1–50.

Rotschafer JC, Zabinski RA, Walker KJ and Vance‐Bryan K (1992) Pharmacotherapy and pharmacodynamics in the management of bacterial infection. Journal of Clinical Pharmacology 32: 1083–1088.

Sanders CC (1991) ARTs versus ASTs: where are we going? Journal of Antimicrobial Chemotherapy 28: 621–623.

Sugarman B and Pesanti E (1980) Treatment failures secondary to in vivo development of drug resistance by microorganisms. Reviews of Infectious Diseases 2: 153–168.

Weinstein L and Dalton AC (1968) Host determinants of response to antimicrobial agents (parts 1–3). New England Journal of Medicine 279: 467–473, 524–531, 580–588.

Further Reading

Lorian V (ed.) (1996) Antibiotics in Laboratory Medicine, 4th edn. Baltimore, MD: Williams and Wilkins.

Shanson DC (1997) Laboratory control of antimicrobial therapy. In: O'Grady F, Lambert HP, Finch RG and Greenwood D (eds) Antibiotic and Chemotherapy pp. 136–143. Edinburgh, UK: Churchill Livingstone.

Stratton CW (1983) Susceptibility testing revisited. In: Stefanini M, Gorstein F and Fink LM (eds) Progress in Clinical Pathology, vol. IX, ,pp. 65–100. New York: Grune and Stratton

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Greenwood, David(Apr 2001) Antibacterial agents: susceptibility In Vitro and In Vivo. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0001995]